The condition previously known as polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome, also referred to as PMOS. The name change is intended to improve diagnosis and care, and may reflect a broader understanding of the condition that goes beyond its effects on the reproductive system. The impact of this change on women's health is being explored, with the condition reportedly affecting a significant number of women worldwide.